Use of Vedolizumab in Immune Checkpoint Inhibitor-associated Enterocolitis
Use of Vedolizumab in Immune Checkpoint Inhibitor-associated Enterocolitis
About this item
Full title
Use of Vedolizumab in Immune Checkpoint Inhibitor-associated Enterocolitis
Author / Creator
Publisher
US: Oxford University Press
Journal title
Inflammatory bowel diseases, 2021-11, Vol.27 (12), p.e147-e147
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
Subjects
More information
Alternative Titles
Full title
Use of Vedolizumab in Immune Checkpoint Inhibitor-associated Enterocolitis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8826165
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8826165
Other Identifiers
ISSN
1078-0998
E-ISSN
1536-4844
DOI
10.1093/ibd/izab159
